HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hubert M Wichowicz Selected Research

Clopenthixol (Zuclopenthixol)

7/2013[Mineralization of the basal ganglia as the supposed cause of poor tolerance of zuclopenthixol in a patient with long-term untreated paranoid schizophrenia].
4/2007Refractory schizophrenia treated with clozapine combined with zuclopenthixol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hubert M Wichowicz Research Topics

Disease

2Stroke (Strokes)
01/2015 - 07/2011
1Paranoid Schizophrenia (Delusional Disorder)
07/2013
1Mental Disorders (Mental Disorder)
07/2013
1Anxiety Disorders (Anxiety Disorder)
07/2011
1Pathologic Complete Response
11/2009
1Dystonia (Limb Dystonia)
11/2009
1Movement Disorders (Movement Disorder)
11/2009
1Dyskinesias (Dyskinesia)
11/2009
1Treatment-Resistant Schizophrenia
04/2007

Drug/Important Bio-Agent (IBA)

2Clopenthixol (Zuclopenthixol)IBA
07/2013 - 04/2007
2Clozapine (Clozaril)FDA LinkGeneric
11/2009 - 04/2007
14-O-carboxymethylascochlorinIBA
01/2015
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
07/2011
1Pharmaceutical PreparationsIBA
11/2009
1Antipsychotic Agents (Antipsychotics)IBA
11/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
07/2013